Key result
Cardiac allograft vasculopathy is the major determinant of long-term survival after heart transplantation, requiring early prevention and diagnosis due to disappointing treatment options.
Cardiac allograft vasculopathy is a major determinant of long-term survival after heart transplantation, with early detection relying on intravascular ultrasound and severe cases ultimately requiring retransplantation.
Answers are grounded in this paper and cite their sources.
Supports enhanced post-transplant surveillance; leaves open effective therapies for cardiac allograft vasculopathy.
Development of cardiac allograft vasculopathy represents the major determinant of long-term survival in patients after heart transplantation. Due to graft denervation, these patients seldom present with classic symptoms of angina pectoris, and the first clinical presentations are progressive heart failure or sudden cardiac death. Although coronary angiography remains the routine technique for coronary artery disease detection, it is not sensitive enough for screening purposes. This is especially the case in the first year after transplantation when diffuse and concentric vascular changes can be easily detected only by intravascular ultrasound. The treatment of the established vasculopathy is disappointing, so the primary effort should be directed toward early prevention and diagnosis. Due to diffuse vascular changes, revascularization procedures are restricted only to a relatively small proportion of patients with favorable coronary anatomy. Percutaneous coronary intervention is preferred over surgical revascularization since it leads to better acute results and patient survival. Although there is no proven long-term advantage of drug-eluting stents for the treatment of in-stent restenosis, they are preferred over bare-metal stents. Severe vasculopathy has a poor prognosis and the only definitive treatment is retransplantation. This article reviews the present knowledge on the pathogenesis, diagnosis, treatment, and prognosis of cardiac allograft vasculopathy.
No takes yet. Share an insight, caveat, or question.
Škorić et al. (2014) conducted a review in Cardiac allograft vasculopathy. Cardiac allograft vasculopathy is the major determinant of long-term survival after heart transplantation, requiring early prevention and diagnosis due to disappointing treatment options.
Synapse has enriched 10 related papers. Consider them for comparative context: